The medicines regulator, Swissmedic, has given the go ahead to the one-shot vaccine from the US company Johnson and Johnson.
Sometimes known as the Janssen Vaccine, it has a 66.9% efficacy rate in those over 18 years old.
The drug was put forward for authorisation in December.
The vaccine has been used in the United States since February.
As yet, there’s no information when it will start to be used.
Govt ready to step in on train staff attacks
Police have to disclose nationality of offenders
Valais bar association says no new fire laws are needed
Major Swiss firm to cut jobs
Post your ballots on time
This winter was significantly warmer than average
